drugset / Trial / NCT02222558

Oral Testosterone for the Treatment of Hypogonadism in Males

NCT02222558

Phase 2 Completed 25 enrolled TesoRx Pharma, LLC
RandomizedParallel-groupOpen-labelTreatment

Summary

Low testosterone is a condition that occurs when the body is unable to produce sufficient quantities of testosterone. The medical name for low testosterone is hypogonadism. Hypogonadism can be caused by many factors. Symptoms include: decrease in libido, lack of energy and mood swings. The goal of testosterone replacement therapy is to return testosterone levels to the normal range and relieve symptoms.

Timeline

Start
2014-09
Primary completion
2015-04
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 60 mg Oral
Subject Testosterone Small molecule 90 mg Oral
Subject Testosterone Small molecule 120 mg Oral
Subject Testosterone Small molecule 180 mg Oral
Subject Testosterone Small molecule 240 mg Oral

Indications